ArticleGynecologic oncology2025

A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.

Jibran Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.